ArticleAmerican journal of cancer therapy and pharmacology2014

A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.

Jianqing Lin et al.PubMed ↗Full text ↗

No numbers read from the abstract.